Skip to content

To compare effect of two different nerve blocks in unilateral total knee replacement

To Evaluate the analgesic efficacy of the anterior femoral cutaneous nerve block (AFCNB) combined with the adductor canal block (ACB) in patients undergoing unilateral total knee replacement (TKR) : A randomized controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063773
Enrollment
80
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Adductor Canal Block: Position the patient in a supine position with the leg to be blocked slightly abducted and externally rotated. This exposes the inguinal region and the anterior th

Sponsors

Josemine Davis
Lead Sponsor
Gaurav Purohit
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years and older undergoing unilateral TKR 2. ASA classification I-III. 3. Patients capable of providing informed consent or with consent provided by a legal guardian. 4. Patients who can comprehend and cooperate with study procedures and pain assessment tools.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications or allergies to local anaesthetics used in nerve block procedures. 2. Patients scheduled for emergency orthopaedic procedures. 3. Patients with chronic opioid use or opioid tolerance. 4. Patients with pre-existing neurological disorders that may affect pain perception. 5. Patients with coagulopathies or those on anticoagulant therapy that cannot be temporarily stopped. 6. Known allergies to components of the nerve block procedures. 7. Patients with active infections or open wounds at the site of the nerve block. 8. Pregnant or lactating women. 9. Patients currently enrolled in other clinical trials or studies involving pain management techniques.

Design outcomes

Primary

MeasureTime frame
To Evaluate Postoperative Pain ReliefTimepoint: At baseline , 24 hours postoperatively

Secondary

MeasureTime frame
To examine functional outcomes: Assess the impact of the AFCNB & ACB on early ambulation & functional recovery in the immediate postoperative period. The Timed Up & Go (TUG) test results at 24 hours postoperatively will be noted in comparison to pre-op TUG test results.Timepoint: 24 hours

Countries

India

Contacts

Public ContactJosemine Davis

Army Hospital Research and Referral

jose2mine@yahoo.com9764623542

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026